Safety and immunogenicity of COVID-19 vaccine ZF2001 in Chinese aged 60 years and older-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Safety and immunogenicity of COVID-19 vaccine ZF2001 in Chinese aged 60 years and older

Published:2024-05 Issue:5 Volume:2 Page:257-261
ISSN:2949-9283
Container-title:hLife
language:en
Short-container-title:hLife

Author:

Gao Lidong,Yang Huijie,He Peng,Yang Shilong,Li Wanjun,Li Fangjun,Xia Wei,Zhang Shangxiao,Wang Xilu,Yuan Lingfeng^ORCID,Wang Ruyue,Xiao Liangliang,Dai Lianpan,Gao George Fu^ORCID,Hu Zhongyu,Zhong Zaixin,Ding Fan,Li Yan^ORCID

Publisher

Elsevier BV

Reference16 articles.

1. Age-related morbidity and mortality among patients with COVID-19;Kang;Infect Chemother,2020

2. COVID-19 and older adults: what we know;Shahid;J Am Geriatr Soc,2020

3. Protecting older people: a high priority during the COVID-19 pandemic;Zhang;Lancet,2022

4. Immunogenicity, efficacy and safety of COVID-19 vaccines: an update of data published by 31 December 2021;Xu;Int Immunol,2022

5. A universal design of betacoronavirus vaccines against COVID-19, MERS, and SARS;Dai;Cell,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP